Skip to content

Pharmacy

NACDS gives input on HHS’ Healthy People 2030 initiative

NACDS gives input on HHS’ Healthy People 2030 initiative

The National Association of Chain Drug Stores (NACDS) has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all

ACPE elects new officers, announces new board members

ACPE elects new officers, announces new board members

CHICAGO – The Accreditation Council for Pharmacy Education (ACPE) announced that Lori Duke, Anthony Provenzano, and Michael Moné have been elected as members of the ACPE executive committee for the 2019–2020 term of office.

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults.

NACDS demonstrates need for DIR fee reform in comments to CMS

NACDS demonstrates need for DIR fee reform in comments to CMS

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to refor

CVS announces organizational changes

CVS announces organizational changes

CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone.

BD launches ergonomic pen needle technology

BD launches ergonomic pen needle technology

BD (Becton, Dickinson and Company), announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed for more reliable subcutaneous injection depth.

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Dofetilide Capsules, 0.125 mg, 0.25 mg, and 0.5 mg. Aurobindo’s dofetilide capsules are an AB-rated generic equivalent to the reference listed drug, Pfizer’s Tikosyn.